Azithromycin treatment of gingival hyperplasia in kidney transplant recipients is effective and safe.
Citterio
F
F
Department of Surgery, Division of Organ Transplantation, Catholic University, Rome, Italy.
Di Pinto
A
A
Borzi
M T
MT
Scatà
M C
MC
Foco
M
M
Pozzetto
U
U
Castagneto
M
M
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use; D019540:Area Under Curve; D017963:Azithromycin / Q000009:adverse effects / Q000627:therapeutic use*; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use; D005500:Follow-Up Studies; D005885:Gingival Hyperplasia / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000502:physiology; D011183:Postoperative Complications; D012008:Recurrence; D013997:Time Factors; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents; D017963:Azithromycin; D016572:Cyclosporine; D003404:Creatinine